India’s medical device sector has experienced significant growth over the past decade, supported by healthcare expansion, technological innovation, and stronger regulatory oversight. A major milestone in this regulatory evolution was the introduction of the Medical Devices Rules, 2017, notified vide G.S.R. 78(E) dated 31 January 2017 by the Ministry of Health and Family Welfare under the Drugs and Cosmetics Act, 1940.
The Medical Devices Rules, 2017 established a dedicated regulatory framework for medical devices in India and introduced a risk-based licensing system governed jointly by the Central Drugs Standard Control Organization (CDSCO) and State Licensing Authorities (SLAs).
Among the most important regulatory bodies under this framework is the State Licensing Authority (SLA), which plays a central role in licensing, inspection, compliance monitoring, and enforcement for specified categories of medical devices.
This article explains the role, powers, responsibilities, and regulatory importance of the State Licensing Authority under G.S.R. 78(E).
The State Licensing Authority (SLA) is the authority designated by the respective State Government under the Medical Devices Rules, 2017 for regulating specified categories of medical devices within the jurisdiction of that state.
In most states, this responsibility is carried out by the State Drug Controller or another designated regulatory officer.
The SLA functions as the primary state-level regulatory authority responsible for:
For medical device manufacturers and distributors, the SLA is often the first point of regulatory interaction at the state level.
India’s medical device industry is geographically widespread and includes manufacturers ranging from small enterprises to multinational companies. Regulating all approvals centrally would create administrative burden and approval delays.
To improve efficiency and strengthen regulatory oversight, the Medical Devices Rules, 2017 introduced a decentralized and risk-based regulatory structure:
This approach allows:
The SLA therefore acts as an important bridge between local enforcement and national regulatory governance.
Under the Medical Devices Rules, 2017, medical devices are classified according to risk as specified in the First Schedule:
The State Licensing Authority is primarily responsible for granting manufacturing licences for:
Manufacturing licences for Class C and Class D devices are regulated by the Central Licensing Authority (CLA) under CDSCO.
One of the primary functions of the SLA is the issuance of manufacturing licences for Class A and Class B medical devices under the Medical Devices Rules, 2017.
These categories may include:
Applications are submitted through the CDSCO Online System for Medical Devices along with required documentation such as:
The SLA reviews the submitted documents and assesses regulatory compliance before granting approval through applicable forms under MDR 2017 such as Form MD-5 and related licensing forms.
The SLA has authority to inspect manufacturing facilities both before and after licence issuance to ensure compliance with the Medical Devices Rules, 2017.
These inspections help ensure continued compliance with:
For certain Class A devices, conformity assessment bodies may also be involved under applicable provisions of MDR 2017.
The SLA also oversees the sale, stocking, exhibition, distribution, and retail activities of medical devices within the state through designated enforcement officers and drug inspectors.
This includes monitoring:
The objective is to ensure that only compliant and approved medical devices are available in the market.
This role is critical because medical devices directly impact patient safety and healthcare outcomes.
The State Licensing Authority has legal authority to take enforcement action under:
Regulatory actions may include:
Grounds for enforcement action may include:
Where necessary, the SLA may coordinate with CDSCO and the Central Licensing Authority for regulatory action.
Manufacturers applying for Class A or Class B manufacturing licences generally follow these steps:
Determine the device classification according to the First Schedule of MDR 2017.
Register on the CDSCO Online System for Medical Devices.
Submit:
The SLA reviews the application and supporting documents.
Inspection may be conducted depending on device classification and regulatory requirements.
If the application satisfies regulatory requirements, the manufacturing licence is granted.
The State Licensing Authority plays an important operational and strategic role for manufacturers.
Local regulatory interaction often enables quicker communication and procedural coordination.
Manufacturers may receive guidance related to:
The SLA provides clarity regarding state-level compliance responsibilities and enforcement expectations.
India’s medical device industry is expected to continue expanding due to:
Accordingly, the role of State Licensing Authorities is expected to expand alongside:
The SLA will continue to remain a key pillar of India’s medical device regulatory framework.
The State Licensing Authority under G.S.R. 78(E) is a vital component of India’s medical device regulatory ecosystem.
By regulating lower-risk medical devices at the state level, the SLA improves licensing efficiency while ensuring compliance with the Medical Devices Rules, 2017 and the Drugs and Cosmetics Act, 1940.
Its responsibilities in licensing, inspections, market surveillance, and enforcement contribute significantly to public health protection and regulatory accountability.
For manufacturers, importers, distributors, and regulatory professionals, understanding the role of the SLA is essential for successful medical device compliance and market access in India.
As India continues to strengthen its medical device sector, the State Licensing Authority will remain central to ensuring device safety, quality, and regulatory governance.
Last Updated : 13 Jun 2026
The Brand That Promises To Turn Your Business Around!